Samuel C. Blackman, Chief Medical Officer at Day One Biopharmaceuticals, Inc. (DAWN), sold 10,000 shares at $21.38 ($215K) on 2022-12-01, disclosed to the SEC on 2022-12-05.
Open-market sale of $215k DAWN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.38 | 9,100 | $195K | 90.7% |
| 2 | $22.16 | 900 | $20K | 9.3% |
| Total | $21.45 avg | 10,000 | $215K | 100% |
| Filing → |
| DAWN | SELL | 2024-11-12 | $751K | — | Filing → |
| DAWN | SELL | 2024-11-08 | $361K | — | Filing → |
| DAWN | SELL | 2024-11-04 | $8K | — | Filing → |